Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • Searching Asian documents: patent search and monitoring services
      • EP full-text search
      • Bibliographic coverage in Espacenet and OPS
      • Full-text coverage in Espacenet and OPS
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Searching Asian documents
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Patent insight reports
    • Data
      • Overview
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge

    UP search

    Learn about the Unitary Patent in patent knowledge products and services

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact on your files
      • Online Filing & fee payment outages
      • Tutorials
    • Find a professional representative
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Unitary Patent

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • EPC Guidelines
      • PCT-EPO Guidelines
      • Guidelines revision cycle
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National law relating to the UP
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives

    legal text

    Legal texts

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • Watch the 2022 ceremony
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Firefighting technologies
      • Green tech in focus
      • CodeFest on Green Plastics
      • Clean energy technologies
      • IP and youth
      • Research institutes
      • Women inventors
      • Fighting coronavirus
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    Listen to our podcast

  • Learning

    Learning

    The e-Academy – the point of access to your learning

    Go to overview 

    • Overview
    • European Patent Academy
      • Overview
      • Learning activities
      • Learning paths
    • Professional hub
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by area by profile
      • Overview
      • Business and IP managers
      • EQE candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)

    European Patent Academy

    Boost your IP knowledge with (e-)training from the European Patent Academy

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • A glimpse of the planned activities
      • Kids’ collaborative art competition
      • 50 Leading Tech Voices
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Governance
      • Overview
      • Communiqués
      • Calendar
      • Select Committee documents
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Public consultation on the EPO's Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Social responsibility
      • Overview
      • Environment and sustainability
      • Art collection
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s

    about us

    Patent Index 2022

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
  • New to patents
    • Go back
    • Overview
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Your business and patents
    • Is it patentable?
    • Are you first?
    • Why do we have patents?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • Searching Asian documents
      • EP full-text search
      • Bibliographic coverage in Espacenet and OPS
      • Full-text coverage in Espacenet
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
            • Go back
            • Overview
            • BG - Federated Register Service
            • GB - Federated Register Service
            • NL - Federated Register Service
            • MK - Federated Register Service
            • ES - Federated Register Service
            • GR - Federated Register Service
            • SK - Federated Register Service
            • FR - Federated Register Service
            • MT - Federated Register Service
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Searching Asian documents
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Patent insight reports
    • Data
      • Go back
      • Overview
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
          • Go back
          • EBD files (weekly download) - free of charge
            • Go back
            • Secure EBD ST.36 files (weekly download) - for national patent offices only
        • Boards of Appeal decisions
        • EP full-text data for text analytics
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Helpful resources
      • Go back
      • Overview
      • First time here? Patent information explained.
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Unitary Patent Guide
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Online Filing 2.0 pilot
        • MyEPO Portfolio - pilot phase
        • Online Filing 2.0 pilot continuation
        • Exchange data with us using an API
      • Get access
        • Go back
        • Overview
        • Installation and activation
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact on your files
      • Online Filing & fee payment outages
      • Tutorials
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • EPC Guidelines
        • Go back
        • Overview
        • Archive
      • PCT-EPO Guidelines
        • Go back
        • Overview
        • Archive
      • Guidelines revision cycle
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • Watch the 2023 ceremony
      • European Inventor Network
        • Go back
        • Activities granted in 2023
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • CodeFest on Green Plastics
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • IP and youth
      • Research institutes
      • Women inventors
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Patents and standards
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • European Patent Academy
      • Go back
      • Overview
      • Learning activities
      • Learning Paths
    • Professional hub
      • Go back
      • Overview
      • EPAC - European patent administration certification
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Archive
        • Candidates successful in the European qualifying examination
        • Compendium
          • Go back
          • Overview
          • Pre-examination
          • Paper A
          • Paper B
          • Paper C
          • Paper D
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
        • Go back
        • Overview
        • Patent enforcement in Europe
        • Patent litigation in Europe
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventors' handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
            • Go back
            • Overview
            • Is the idea ‘obvious’?
            • Prior art searching
            • Professional patent searching
            • Simple Espacenet searching
            • What is prior art?
            • Why is novelty important?
          • Competition and market potential
            • Go back
            • Overview
            • Research guidelines
          • Assessing the risk ahead
            • Go back
            • Overview
            • Exploitation routes
            • Significant commercial potential
            • Significant novelty
            • What about you?
            • What if your idea is not novel but does have commercial potential?
          • Proving the invention
            • Go back
            • Overview
            • Help with design or redesign
            • Prototype strategy
          • Protecting your idea
            • Go back
            • Overview
            • Forms of IPR
            • Patenting strategy
            • The patenting process
          • Building a team and seeking funding
            • Go back
            • Overview
            • Building a team
            • Sources of funding
            • Sources of help for invention
          • Business planning
            • Go back
            • Overview
            • Constructing a business plan
            • Keep it short!
          • Finding and approaching companies
            • Go back
            • Overview
            • First contact
            • Meetings
          • Dealing with companies
            • Go back
            • Overview
            • Advance or guaranteed payment
            • Companies and your prototype
            • Full agreement – and beyond
            • Negotiating a licensing agreement
            • Reaching agreement
            • Royalties
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • For IP professionals
          • For business decision-makers
          • For stakeholders of the innovation ecosystem
        • IP clinics
      • EQE Candidates
        • Go back
        • Overview
        • Coffee-break questions
        • Daily D questions
        • European qualifying examination - Guide for preparation
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Overview
      • 50 Leading Tech Voices
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Governance
      • Go back
      • Overview
      • Communiqués
        • Go back
        • Overview
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • About eTendering
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • Invoicing
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • EPO Data Hub
      • Clarification on data sources
    • Social responsibility
      • Go back
      • Overview
      • Environment
      • Art collection
        • Go back
        • Overview
        • The collection
        • Let's talk about art
        • Artists
        • Media library
        • What's on
        • Publications
        • Contact
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Procedure
    • Annual reports
      • Go back
      • Overview
    • Organisation
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
        • Composition of the Presidium
          • Go back
          • Overview
          • Archive
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2023
      • Archive
    • Annual list of cases
    • Communications
    • Publications
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
    • Case Law from the Contracting States to the EPC
    • Oral proceedings
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Legal resources
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
      • Specific contact
      • Surveys
        • Go back
        • Overview
        • Search services
        • Examination services, final actions and publication
        • Opposition services
        • Patent filings
          • Go back
          • Overview
          • Detailed methodology
          • Archive
        • Online Services
        • Patent information
          • Go back
          • Overview
          • Innovation process survey
        • Customer services
        • Filing services
        • Website
        • Survey on electronic invoicing
        • Companies innovating in clean and sustainable technologies
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Forums
    • Glossary
Board of Appeals
Decisions

Recent decisions

Overview
  • 2023 decisions
  • 2022 decisions
  • 2021 decisions
https://www.epo.org/en/node/t150703eu1
  1. Home
  2. T 0703/15 29-06-2017
Facebook Twitter Linkedin Email

T 0703/15 29-06-2017

European Case Law Identifier
ECLI:EP:BA:2017:T070315.20170629
Date of decision
29 June 2017
Case number
T 0703/15
Petition for review of
-
Application number
07752891.7
IPC class
A61L 27/54
A61L 29/16
A61L 31/16
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 329.26 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

TAXANE COATINGS FOR IMPLANTABLE MEDICAL DEVICES

Applicant name
Cook Medical Technologies LLC
Opponent name
Withers&Rogers LLP/N.Wallin/H.Wright/A.Tombling
Board
3.3.10
Headnote
-
Relevant legal provisions
European Patent Convention Art 100(b)
Keywords
Sufficiency of disclosure - (no)
Catchword
-
Cited decisions
T 0409/91
T 0435/91
Citing decisions
-

I. The appellant (opponent) lodged an appeal against the interlocutory decision of the opposition division which maintained European patent 1 996 246 in the form of the then pending auxiliary request 2, which is the main request of the respondent (patent proprietor) in these appeal proceedings.

II. Notice of opposition had been filed inter alia on the ground of insufficiency of disclosure (Article 100(b) EPC).

III. The opposition division concluded that the invention was disclosed in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art, as the parametric definitions in claim 1 were redundant since they were inherent properties of dihydrate paclitaxel and amorphous paclitaxel.

IV. With the statement setting out the grounds of appeal, the respondent filed auxiliary requests 1 to 8. Auxiliary request 9 was filed during the oral proceedings before the board, which took place on 29 June 2017.

V. Claim 1 of the main request and of auxiliary request 6 reads as follows:

"A coated implantable medical device comprising an implantable medical device having at least one surface and a coating on the at least one surface, wherein the coating comprises a first layer comprising a taxane therapeutic agent in a first taxane solid form having a vibrational spectrum including at least two peaks between 1735 and 1705 cm**(-1) and having a solubility of less than 20% wt. after 24 hours in porcine serum at 37ºC, the first layer positioned between the abluminal surface of the medical device and a second layer comprising a taxane therapeutic agent in a second taxane solid form having a vibrational spectrum including only one peak between 1735 and 1705 cm**(-1) and having a solubility of greater than 50% wt. after 24 hours in porcine serum at 37ºC; wherein said first taxane solid form is dihydrate paclitaxel and said second taxane solid form is paclitaxel in an amorphous solid form."

Claim 1 of auxiliary request 1 contains, in addition to the feature of claim 1 of the main request, the following:

"and wherein the coating is free of a polymer."

Claim 1 of auxiliary requests 2 and 7 contains all the features of claim 1 of the main request, adding that

"and wherein at least 20% of the first layer comprises the taxane therapeutic agent in the first taxane solid form."

Claim 1 of auxiliary requests 3 and 8 contains all the features of claim 1 of the main request adding that

"wherein more than 50% of the first layer comprises the taxane therapeutic agent in the first taxane solid form; and wherein more than 50% of the second layer comprises the taxane therapeutic agent in the second taxane solid form."

Claim 1 of auxiliary request 4 combines the features of claim 1 of auxiliary requests 1 and 2. Similarly, claim 1 of auxiliary request 5 combines the features of claim 1 of auxiliary requests 1 and 3.

Lastly, claim 1 of auxiliary request 9 contains all the features of claim 1 of the main request and, in addition, the following:

"wherein the porcine serum has a constant flow rate of 16 mL/min; and wherein the porcine serum is a modified porcine serum prepared by adding 0.104 mL of a 6.0 g/L heparin solution to porcine serum at 37ºC and adjusting the pH to 5.6 +/- 0.3 using a 20% v/v aqueous solution of acetic acid."

VI. The arguments of the appellant relevant for the present decision were the following:

The claimed invention was not sufficiently disclosed, as the patent in suit did not describe how to prepare medical devices with a coating containing a layer comprising dihydrate paclitaxel having a solubility of less than 20% wt. after 24 hours in porcine serum at 37ºC. This feature did not describe the solubility of dihydrate paclitaxel, but related to the whole coating layer. In view of the discrepancy between the term "solubility" and the units in which it was expressed, the feature should be interpreted as meaning the solubility rate. The data provided in the patent in suit showed that dihydrate paclitaxel in the coating required by claim 1 did not have the required solubility and, for that reason, the claimed invention was insufficiently disclosed. The appellant also requested that auxiliary request 9 not be admitted into the proceedings.

VII. The arguments of the respondent relevant for the present decision were the following:

"Solubility" was a thermodynamic property and had a clear meaning, so that the description of the patent in suit did not need to be taken into consideration for interpreting it. It referred to the amount of paclitaxel dissolved in porcine serum in equilibrium with its solid form. Paclitaxel dihydrate inherently had a solubility of less than 20% wt. after 24 hours in porcine serum at 37ºC, so the latter feature was in fact redundant.

Even if the required solubility were not an inherent property of paclitaxel dihydrate, the skilled person would not have any difficulty in achieving the required solubility, either by using less porcine serum, by increasing the amount of paclitaxel in the coating, or by measuring solubility under static conditions.

For these reasons, the claimed invention was sufficiently disclosed.

VIII. The final requests of the parties were the following:

- The appellant requested that the decision under appeal be set aside and that the patent be revoked.

- The respondent requested that the appeal be dismissed, i.e. that the patent be maintained as upheld by the opposition division, or, alternatively, that the patent be maintained on the basis of one of auxiliary requests 1 to 9, filed with letter dated 24 December 2015 (auxiliary requests 1 to 8) and in the oral proceedings before the board (auxiliary request 9).

IX. At the end of the oral proceedings, the decision was announced.

1. The appeal is admissible.

Sufficiency of disclosure

2. According to the case law of the Boards of Appeal, the requirements of sufficiency of disclosure are met only if the claimed invention can be performed by a person skilled in the art without undue burden over the whole area claimed, using common general knowledge and having regard to the information in the patent in suit (T 409/91, OJ 1994, 653, Reasons 3.5; T 435/91, OJ 1995, 188, Reasons 2.2.1).

3. Claim 1 is directed to a medical device having a coating with "a first layer comprising a taxane therapeutic agent in a first taxane solid form having a vibrational spectrum including at least two peaks between 1735 and 1705 cm**(-1) and having a solubility of less than 20% wt. after 24 hours in porcine serum at 37ºC". This first taxane solid form is dihydrate paclitaxel.

4. The first issue to be examined is the meaning of the term "solubility" in claim 1. It is not disputed that the units in claim 1 do not correspond to the usual thermodynamic property solubility, which is normally defined as the amount of a compound dissolved in a solvent and is therefore expressed as a concentration. Instead, the units used for "solubility" in claim 1 are weight percent per amount of time.

Thus, the skilled person, in view of the discrepancy between the normal definition of "solubility" and the units employed in claim 1, would seek guidance in the patent in suit.

4.1 With the exception of claim 1, each time the patent in suit uses the unit weight percent per amount of time, dissolution rates are concerned (figures 6, 7, 9).

In addition, in general, units define a physical quantity more accurately than names. The skilled reader will for this reason consider the feature "solubility" in claim 1 to refer to dissolution rates, as it includes time as a variable (weight percent after 24 hours).

4.2 The respondent argued that the term solubility in claim 5 had usual meaning, and that there was no need to rely on the description in order to interpret it.

However, this argument is not convincing, since the units used in claim 1 do not correspond to the normal meaning of "solubility".

4.3 The respondent further argued that paragraph [0139] of the patent in suit disclosed that the rate of elution of amorphous paclitaxel in porcine serum at 25ºC was about 100 times faster than that of dihydrate paclitaxel. In contrast, the difference in "solubility" required by claim 1 was far lower. The skilled reader would thus deduce that the percentages in claim 1, which were of the same order of magnitude, could not refer to solubility rates.

However, the percentages in claim 1 (less than 20%, more than 50%) also cover the situation in which the elution rate of one form is 100 times faster than that of the other, as disclosed in paragraph [0139]. Thus, there is no reason why the passage on paragraph [0139] should lead to the conclusion put forward by the respondent.

5. The other issue to be examined in this context is whether, as the opposition division concluded and the respondent argued in these appeal proceedings, the "solubility" indicated in claim 1 is an inherent property of dihydrate paclitaxel, and thus redundant in claim 1, or whether, as argued by the appellant, said feature further restricts the claimed subject-matter.

5.1 The respondent argued that, from a purely grammatical pointview, the feature referred to the "solubility" of the taxane form, i.e. of dihydrate paclitaxel. Claim 1 contained two parametric requirements, namely a specific vibrational spectrum and a specific "solubility". It was apparent that the vibrational spectrum related to the taxane form per se, as a vibrational spectrum of a coating could not be measured, and there was no reason why the feature "solubility" should be any different.

5.2 It is not disputed that the patent in suit does not disclose any link between the required "solubility" threshold, which only appears in the claims of the patent specification, and either paclitaxel dihydrate or any other taxane solid form.

Figure 9 discloses (line 922) that after 24 hours (1440 minutes) the percentage of a coating consisting only of dihydrate paclitaxel, which is a preferred embodiment of claim 1, dissolved in porcine serum is already more than 20% at 25ºC. At 37ºC, as required by claim 1, this percentage will be even higher. Thus, the patent in suit provides evidence that not every coating containing dihydrate paclitaxel has the "solubility" required by claim 1.

For this reason alone, it is thus concluded that the feature "having a solubility of less than 20% wt. after 24 hours in porcine serum at 37ºC" is not made redundant by the feature "said first taxane solid form is dihydrate paclitaxel".

6. A particularly preferred embodiment of the present invention - [0009], [0011], [0012], examples, claim 4 - relates to a medical device having a coating whose layers consist essentially of solid paclitaxel, whereby said layers comprise either only one paclitaxel form, or combinations of dihydrate and amorphous paclitaxel. According to the most preferred embodiment of the claimed invention, the coating layer does not include polymers which retard the solubility of the taxanes present (claim 4 of the main request).

6.1 In the following, it will be examined whether these most preferred embodiments are sufficiently disclosed, i.e. whether or not the patent in suit has made available to the skilled reader an implantable medical device having a first layer comprising a taxane which is dihydrate paclitaxel, having a "solubility" of less than 20% wt. after 24 hours in porcine serum at 37ºC, by disclosing at least one way to carry out the invention, by providing sufficient instructions, or by relying on the skilled reader's common general knowledge.

6.2 In this context, the most favourable interpretation of the feature "solubility" for the respondent is that it refers to dihydrate paclitaxel present in the coating, and not to the solubility of the whole coating, as the solubility of a coating comprising a mixture of slower-dissolving dihydrate [0143] and faster-dissolving amorphous paclitaxel [0143] will necessarily dissolve faster than dihydrate paclitaxel alone.

6.3 It is not disputed that none of the coatings disclosed in the patent in suit has a "solubility" below the required threshold.

It is further not disputed that the patent in suit does not provide any teaching on how to change the "solubility" of dihydrate paclitaxel to bring it below the required threshold.

The respondent has relied on general technical knowledge, and argued that the skilled person would not have any difficulty in providing dihydrate paclitaxel having the required "solubility" by either

- using less porcine serum, or

- increasing the amount of dihydrate paclitaxel, or

- measuring it under static conditions.

6.4 The claimed devices are intended to release paclitaxel within a body vessel [0040]. It can thus be assumed that the "solubility" conditions required by claim 1, which the respondent acknowledges are not fully defined, should mimic the conditions in such a vessel. For this reason, the skilled person would rule out using small amounts of porcine serum or static conditions.

6.5 With respect to the argument that the skilled person could increase the amount of dihydrate paclitaxel in the coating in order to reduce the "solubility" below the threshold defined in claim 1, figure 6C of the patent in suit discloses the elution of dihydrate paclitaxel in porcine serum at 25ºC. Elution profiles 732-734, which correspond to stents coated with a 7:3 mixture of amorphous and dihydrate paclitaxel, show that, as argued by the respondent, a lower elution rate of dihydrate paclitaxel can be achieved by increasing its paclitaxel content.

In contrast, elution profiles 736-738, which relate to stents coated with a 4:1 mixture of amorphous and dihydrate paclitaxel lead to the opposite result, i.e. an increase of the total amount of paclitaxel coating implied a slower elution rate.

Thus, the experimental data in the patent in suit does not support the argument of the respondent that the "solubility" could be reduced by increasing the amount of paclitaxel in the coating, as this is not always the case.

6.6 As the dissolution rate of amorphous paclitaxel is 100 times higher than that of dihydrate paclitaxel [143], any combination of dihydrate and amorphous paclitaxel will dissolve even faster (lines 904 to 920).

7. The appellant has not relied on any further evidence showing that, at the date of filing, a skilled person knew how to obtain a coating comprising dihydrate paclitaxel having the required "solubility".

As the application does not contain the required information allowing a skilled person to obtain medical devices comprising a coating containing dihydrate paclitaxel having a "solubility" of less than 20% wt. after 24 hours in porcine serum at 37ºC, the board concludes that the subject-matter of claim 1 of the main request is not disclosed in a manner sufficiently clear and complete for it to be carried out by such a person, and thus that the ground under Article 100(b) EPC precludes the maintenance of the patent as granted.

8. It is not disputed that the situation with respect to sufficiency of disclosure is the same for claim 1 of any of the auxiliary request on file, and that the arguments set out above also apply mutatis mutandis, with the consequence that none of the requests on file is allowable.

9. In these circumstances, it is not necessary to decide whether or not auxiliary request 9 is admitted into the proceedings.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.

Footer - Service & support
  • Service & support
    • FAQ
    • Contact us
    • Subscription centre
    • Official holidays
    • Publications
    • Procedural communications
    • Ordering
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
SoMe facebook 0
European Patent Office
EPO Jobs
SoMe instagram
EuropeanPatentOffice
SoMe linkedIn
European Patent Office
EPO Jobs
EPO Procurement
SoMe twitter
EPOorg
EPOjobs
SoMe youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility